Diagnosis, phenotype, and prevalence of polycystic ovary syndrome

被引：79

作者：

Carmina, Enrico

Azziz, Ricardo

机构：

[1] Univ Palermo, Dept Clin Med, I-90139 Palermo, Italy

[2] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA USA

[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA

来源：

FERTILITY AND STERILITY | 2006年 / 86卷

关键词：

polycystic ovary-syndrome; anovulation; hyperandrogenism;

D O I：

10.1016/j.fertnstert.2006.03.012

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

New diagnostic criteria for polycystic ovary syndrome (PCOS) suggested three main phenotypes: classic: (hyperandrogenism and anovulation), ovulatory, and normoandrogenic. However, it is unclear whether the normoandragenic phenotype actually represents :PCOS: Overall, 6% to 8% of reproductive-aged women suffer, from PCOS, making this disorder one of the most common endocrine abnormalities.

引用

收藏

页码：S7 / S8

页数：2

相关论文

共 8 条

[1] The prevalence and features of the polycystic ovary syndrome in an unselected population [J].

Azziz, R ;

Woods, KS ;

Reyna, R ;

Key, TJ ;

Knochenhauer, ES ;

Yildiz, BO .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749

[2] Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters [J].

Carmina, E ;

Chu, MC ;

Longo, RA ;

Rini, GB ;

Lobo, RA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2545-2549

[3] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J].

Chang, J ;

Azziz, R ;

Legro, R ;

Dewailly, D ;

Franks, S ;

Tarlatzis, BC ;

Fauser, B ;

Balen, A ;

Bouchard, P ;

Dahlgren, E ;

Devoto, L ;

Diamanti, E ;

Dunaif, A ;

Filicori, M ;

Homburg, R ;

Ibanez, L ;

Laven, J ;

Magoffin, D ;

Nestler, J ;

Norman, RJ ;

Pasquali, R ;

Pugeat, M ;

Strauss, J ;

Tan, S ;

Taylor, A ;

Wild, R ;

Wild, S ;

Ehrmann, D ;

Lobo, R .

FERTILITY AND STERILITY, 2004, 81 (01) :19-25

[4] Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups [J].

Chang, WY ;

Knochenhauer, ES ;

Bartolucci, AA ;

Azziz, R .

FERTILITY AND STERILITY, 2005, 83 (06) :1717-1723

[5] HOW COMMON ARE POLYCYSTIC OVARIES IN NORMAL WOMEN AND WHAT IS THEIR SIGNIFICANCE FOR THE FERTILITY OF THE POPULATION [J].

CLAYTON, RN ;

OGDEN, V ;

HODGKINSON, J ;

WORSWICK, L ;

RODIN, DA ;

DYER, S ;

MEADE, TW .

CLINICAL ENDOCRINOLOGY, 1992, 37 (02) :127-134

[6] HYPERSECRETION OF ANDROSTENEDIONE BY ISOLATED THECAL CELLS FROM POLYCYSTIC OVARIES [J].

GILLINGSMITH, C ;

WILLIS, DS ;

BEARD, RW ;

FRANKS, S .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04) :1158-1165

[7] Polycystic ovary syndrome in Mexican-Americans:: prevalence and association with the severity of insulin resistance [J].

Goodarzi, MO ;

Quiñones, MJ ;

Azziz, R ;

Rotter, JI ;

Hsueh, WA ;

Yang, HY .

FERTILITY AND STERILITY, 2005, 84 (03) :766-769

[8]

zawadzki JK., 1992, POLYCYSTIC OVARY SYN, P377